---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-030269"
form_type: "8-K"
ticker: "CLNN"
cik: "0001822791"
company_name: "Clene Inc."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:50:39.035058+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Clene amends loan with Avenue; Oct payment cut to $2M, interest-only period tied to equity raise and ALS NDA progress

## Summary
- October 2024 principal payment reduced from $3.33M to $2M.
- Interest-only period from Nov-Dec 2024 contingent on raising $10M in equity by Oct 31, 2024; $7M raised in Sep 2024.
- If FDA allows ALS NDA submission for CNM-Au8 by Dec 31, 2024, loan amortization extends to June 2025; otherwise full repayment by April 2025.
- Warrant exercise price lowered from $16.00 to $4.6014 per share for Avenue.

## SEC filing metadata
- accession: 0001437749-24-030269
- form_type: 8-K
- ticker: CLNN
- cik: 0001822791
- company_name: Clene Inc.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/0001437749-24-030269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/clnn20240928c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-030269
- JSON: https://secwatch.observer/filing/0001437749-24-030269.json
- Plain text: https://secwatch.observer/filing/0001437749-24-030269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.